NCT06902974View on ClinicalTrials.gov

Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

October 31, 2027

Conditions
Post Traumatic Stress DisorderPTSD
Interventions
DRUG

Psilocybin 25 mg

Single dose, 25mg psilocybin, encapsulated, oral administration

Trial Locations (1)

20850

Sunstone Medical, PC, Rockville

All Listed Sponsors
lead

Sunstone Medical

OTHER